Prospects for New Drug Treatment in Epilepsy: A Review

Goodridge D.M.G. , Shorvon S.D. Epileptic seizures in a population of 6000: II: treatment and prognosis. Br Med J 1983; 287: 645–7

Dam M. , Richens A. Fifty years of phenytoin. International Congress and Symposium Series, No. 120. London: Royal Society of Medicine, 1987

Chadwick D. Comparison of monotherapy with valproate and other antiepileptic drugs in the treatment of seizure disorders. Am J Med 1988; 84(Suppl 1A): 6

Chadwick D. , Reynolds E.H. When does epilepsy need treatment? Starting and stopping medication. Br Med J 1985; 290: 1885–8

Reynolds E.H. , Shorvon S.D. Monotherapy or polytherapy for epilepsy? Epilepsia 1981; 22: 1–10

Chadwick D. Overuse of monitoring of blood concentrations of antiepileptic drugs. Br Med J 1987; 294: 723–4

Annegers J.F. , Hauser W.A. , Elveback L.R. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979; 20: 729–37

Porter R.J. Antiepileptic drugs: efficacy and inadequacy. In: Meldrum B.S. , Porter R.J. , eds. New antiepileptic drugs. London: John Libbey, 1986: 3–15

Jackson J.H. On the anatomical, physiological and pathological investigation of epilepsies. West Riding Lunatic Asylum Medical Reports, 1873: 315

Bernado L.A. , Pedley T.A. Cellular mechanisms of focal epileptogenesis. In: Meldrum B.S. , Pedley T.A. , eds. Recent advances in epilepsy. New York: Raven Press, 1985: 1–19

Prince D. Neuronal events underlying focal epileptiform potentials. In: Wiesser H.G. , Speckmann E.J. , Engel J. , eds. The epileptic focus. London: John Libbey, 1989: 17–26

Wong R.K.S. , Prince D.A. Participation of calcium spikes during intrinsic burst firing in hippocampal neurons. Brain Res 1978; 159: 385–90

Meldrum B.S. Epilepsy and GABA-mediated inhibition. Int Rev Neurobiol 1975; 17: 1–36

Chadwick D. New therapeutic horizons in epilepsy. In: Kennard C. , ed. Recent advances in neurology, vol. 7. Edinburgh: Churchill-Livingstone, 1990 (in press)

Olsen R.W. The GABA postsynaptic membrane receptor ionophone complex: site of action of convulsant and anticonvulsant drugs. Molec Cell Biochemist 1981; 39: 261–79

Chapman A.G. , Keane P.E. , Meldrum B.S. , Simiand J. , Vernires J.C. Mechanism of action of valproate. Prog Neurobiol 1982; 19: 315–59

Meldrum B.S. Is epilepsy a disorder of excitatory transmission? In: Trimble M.R. , Reynolds E.H. , eds.What is epilepsy? Edinburgh: Churchill Livingstone, 1986: 293–302

Watkins J.C. , Evans R.H. Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol 1981; 21: 165–204

Davies J. , Evans R.H. , Smith D.A.S. , Watkins J.C. Differential activation and blockade of excitatory amino acid receptors in the mammalian and amphibian central nervous system. Comp Biochem Physiol 1982; 72C: 211–24

Herrling P.L. , Morris R. , Salt T.E. Effects of excitatory amino acids and their antagonists on membrane and action potentials of cat caudate neurones. J Physiol 1983; 339: 207–22

Troupin A.S. , Mendins J.R. , Cheng F. , Risinger M.W. MK801. In: Meldrum B.S. , Porter R.J. , eds. New anticonvulsant drugs London: John Libbey, 1986: 191–202

Meldrum B.S. , Porter R.J. New antiepileptic drugs. London: John Libbey, 1986

Jung M.J. , Lippert B. , Metcalf B.W. , Bohlen P. , Schechter P.J. Gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977; 29: 797–802

Grove J. , Schechter P.J. , Tell G. Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebro-spinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-ecoic-acid). Life Sci 1981; 28: 2431–39

Butler W.H. , Ford G.P. , Newberne J.W. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-hooded rats. Toxicol Pathol 1987; 15: 143–8

J-J Hauw , Trottier S. , Boutry J-M , Sun P. , Sazdovitch V. The neuropathology of vigabatrin. Br J Clin Pract 1988; 42(Suppl 61): 10–13.

John R.A. , Rimmer E.M. , Williams J. , Cole G. , Fowler L.J. , Richens A. Micro-vacuolation in rat brains after long-term administration of GABA-transaminase inhibitors. Biochem Pharmacol 1987; 36: 1467–73

Worms P. , Depoortere H. , Durand A. , Morselli P.L. , Lloyd K.G. , Bartholini G. Gamma-aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76 002) and SL 75 102, with emphasis on their anticonvulsant spectra. J Pharmacol Exp Ther 1982; 220: 660–71

Morselli P.L. , Bartholini G. , Lloyd K.G. Progabide. In: Meldrum B.S. , Porter R.J. , eds. New antiepileptic drugs. London: John Libbey, 1986: 237–53

Crawford P. , Chadwick D. A comparative study of progabide, valproate and placebo as add-on therapy in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry 1986; 49: 1251–7

Coquelin J.P. , Krall R. , Bossi L. , Musch B. , Morselli P.L. Drug safety profile of progabide. In: Bartholini G. , Friedmann J.C. , Langer S.Z. , Morselli P.L. , eds. Epilepsy and GABA receptor agonists: basic and therapeutic research. New York: Raven Press, 1985: 431–40

Schimdt B. Gabapentin. In: Levy R. , ed. Antiepileptic drugs, vol. 3. New York: Raven Press, 1989: 925–35

Crawford P. , Ghadiali E. , Lane R. , Blumhardt L. , Chadwick D. Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry 1987; 50: 682–6

UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990 (in press)

Reynolds E.H. , Milner G. , Matthews D.M. , Chanarin I. Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism. Q J Med 1966; 35: 521–37

Binnie C.D. , Van Emde Boas W. , Land G.S. , Meijer J.W.A. , Overweg J. , Van Wieringen A. Preliminary single-dose studies of a potential new antiepileptic drug, lamotrigine (BW430C) in epileptic patients. Br J Clin Pharmacol 1985; 20: 285

Jawad S. , Oxley J.R. , Yuen W.C. , Richens A. Reduction of interictal electroencephalographic spikes by lamotrigine in epileptic patients. Br J Clin Pharmacol 1985; 20: 287

Jawad S. , Richens A. , Goodwin G. , Yuen W.C. Controlled trial of Lamotrigine for refractory partial seizures. Epilepsia 1989; 30: 356–63